Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD
17.10
0.00 (0.00%)
At close: Jan 23, 2026
HKG:3378 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 2.2 | 2.54 |
| 2.2 | 2.54 |
| -13.39% | - |
| 2.2 | 2.54 |
| 46.19 | 17.22 |
| 74.72 | 46.66 |
| 120.91 | 63.88 |
| -118.71 | -61.34 |
| -9.38 | -2.28 |
Interest & Investment Income | 2.92 | 4.13 |
Currency Exchange Gain (Loss) | 0.94 | - |
EBT Excluding Unusual Items | -124.23 | -59.5 |
Gain (Loss) on Sale of Investments | 1.41 | -33.92 |
| -122.82 | -93.42 |
| -5.9 | -8.26 |
Earnings From Continuing Operations | -116.92 | -85.16 |
Minority Interest in Earnings | 1.09 | 9.1 |
| -115.83 | -76.06 |
| -115.83 | -76.06 |
Shares Outstanding (Basic) | 11 | 7 |
Shares Outstanding (Diluted) | 11 | 7 |
| 49.83% | - |
| -10.60 | -10.42 |
| -10.60 | -10.42 |
| -111.1 | -56.23 |
| -10.16 | -7.71 |
| 100.00% | 100.00% |
| -5398.55% | -2416.07% |
| -5267.39% | -2995.51% |
| -5052.48% | -2214.49% |
| -116.7 | -60.83 |
| 2.02 | 0.52 |
| -118.71 | -61.34 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.